The global race for weight loss solutions has firmly arrived in India—bringing with it hope, hype, and a host of unanswered ...

Galmed Pharmaceuticals Ltd. ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for cardiometabolic diseases and GI oncological indications announced today that it has signed a ...

Tirzepatide (Mounjaro) launched in India in March 2025, promising new hope for diabetes and obesity treatment. An expert breaks down its benefits, downsides and the need for responsible rollout in a ...

Amman, Jordan: Hikma Pharmaceuticals PLC (Hikma, Group), the multinational pharmaceutical group, today provides an update on ...

AZ and Regeneron will collaborate on finding small-molecule drugs directed against ... Nordisk's once-daily injectable weight loss therapy Saxenda (liraglutide) has been a slow grower, but is ...

In North America we are benefitting from good demand for the recently launched liraglutide injection and ... an innovative small-molecule oral oncology therapy, across the MENA region.

These speculative interactions make Liraglutide an interesting molecule for investigations related to hormonal homeostasis and metabolic flexibility. Microbiome and Gut-Brain Axis The gut ...